Noninvasive Evaluation of Antiangiogenic Effect in a Mouse Tumor Model by DCE-MRI with Gd-DTPA Cystamine Copolymers
- 3 December 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 7 (1), 41-48
- https://doi.org/10.1021/mp900153f
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapyJournal of Magnetic Resonance Imaging, 2009
- Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agentsMagnetic Resonance Imaging, 2009
- Characterization of tumor angiogenesis with dynamic contrast‐enhanced MRI and biodegradable macromolecular contrast agents in miceMagnetic Resonance in Medicine, 2008
- VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospectsTrends in Molecular Medicine, 2007
- Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignanciesClinical Therapeutics, 2006
- Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochemical and Biophysical Research Communications, 2005
- Contrast‐enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor‐bearing miceMagnetic Resonance in Medicine, 2005
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- New Approaches to the Treatment of Hepatic Malignancies Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver MetastasisAnnals of Surgical Oncology, 2003
- Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive techniqueMagnetic Resonance in Medicine, 1993